WaveMan · Form 4
Ye Weiguo insider trades
> Search tickers & screens ⌘K
LIVE

Ye Weiguo insider trades

Ye Weiguo has filed 12 Form 4s with the SEC that we hold, all for Gyre Therapeutics, INC. (GYRE), as Chief Operating Officer. Across all of them we count 0 purchases worth $0 and 16 sales worth $869.9K reported on Form 4. In the last 12 months: 0 purchases ($0) and 16 sales ($869.9K). The largest single trade was a sale of 19,575 shares of Gyre Therapeutics, INC. worth $120.0K, dated 2026-06-04. The first filing on our record is dated 2023-11-22 and the latest 2026-06-22.

Gyre Therapeutics, INC. (GYRE)

Chief Operating Officer · 12 filings · 16 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-05-14S, sale reported on Form 415,580$107.7K2026-05-18
2026-05-15S, sale reported on Form 413,100$87.1K2026-05-18
2026-05-18S, sale reported on Form 4200$1.3K2026-05-20
2026-05-19S, sale reported on Form 49,120$58.1K2026-05-20
2026-05-20S, sale reported on Form 49,400$57.8K2026-05-22
2026-05-21S, sale reported on Form 412,820$78.8K2026-05-22
2026-05-22S, sale reported on Form 43,500$21.3K2026-05-27
2026-05-26S, sale reported on Form 44,000$24.4K2026-05-27
2026-06-04S, sale reported on Form 419,575$120.0K2026-06-08
2026-06-05S, sale reported on Form 415,401$98.6K2026-06-08
2026-06-09S, sale reported on Form 43,000$18.4K2026-06-22
2026-06-09S, sale reported on Form 414,500$89.0K2026-06-11
2026-06-10S, sale reported on Form 45,000$31.2K2026-06-22
2026-06-10S, sale reported on Form 46,418$39.9K2026-06-11
2026-06-11S, sale reported on Form 42,800$17.3K2026-06-15
2026-06-18S, sale reported on Form 43,000$19.1K2026-06-22
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1985496) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms